Roche Reports 7% Growth in Full-Year Sales, Strength in Pharmaceuticals
Swiss pharmaceutical giant Roche (SWX: ROG) released its Q4 and full-year 2024 financials, reporting a...
Finanical Reports
Sanofi Reports Strong Q4 Growth, Plans EUR 5 Billion Share Buyback
French pharmaceutical giant Sanofi (NASDAQ: SNY) reported a strong fourth-quarter performance with 10.3% year-on-year (YOY)...
AbbVie’s 2024 Revenue Grows Despite Humira Decline, Skyrizi and Rinvoq Surge
US-based pharmaceutical giant AbbVie (NYSE: ABBV) reported its 2024 financial results on January 31, with...
Roche Reports 7% Revenue Growth in 2024, Driven by Oncology and Ophthalmology
Roche (SWX: ROG) released its 2024 annual financial report on January 30, showing a 7%...
Johnson & Johnson Reports Q4 Growth, Projects 2025 Sales Outlook
US-based Johnson & Johnson (J&J, NYSE: JNJ) has released its Q4 2024 financial results, reporting...
Abbott Labs Posts Q4 Growth, Projects Strong 2025 Outlook
US-based Abbott Laboratories (NYSE: ABT) has released its Q4 2024 financial results, reporting an 8.8%...
Junshi Biosciences Forecasts 29.71% Revenue Growth for 2024
China-based Shanghai Junshi Biosciences Co., Ltd (HKG: 1877, SHA: 688180) has released its 2024 annual...
Alibaba Health Reports 10.2% Revenue Growth and 72.8% Profit Increase in 2024 H1 Financials
China-based Alibaba Health Information Technology Ltd (HKG: 0241) has released its financial report for the...
Burning Rock Ltd Reports Q3 2024 Financials with Revenue Growth and R&D Reduction
China-based medtech firm Burning Rock Ltd (NASDAQ: BNR) has released its financial results for the...
Danish Pharma H. Lundbeck A/S Sees Strong Q3 and Q1-Q3 2024 Financial Results
Denmark-based pharmaceutical company H. Lundbeck A/S (OTCMKTS: HLBBF) has revealed its financial results for the...
Medtronic Reports 5% Organic Revenue Growth in Q2 FY25 with Strong Portfolio Performance
US-Irish medical device company Medtronic (NYSE: MDT) has announced its financial results for the second...
Merck KGaA Reports 3.8% Organic Growth in Q3 2024 Financials
Merck KGaA (NYSE: MRK), the German multinational science and technology company, has released its financial...
FibroGen Inc. Reports 15% YOY Revenue Growth in Q3 2024 Led by Evrenzo
US-based biopharmaceutical company FibroGen Inc. (NASDAQ: FGEN) has released its Q3 2024 financial report, showing...
AstraZeneca Inc. Reports 21% YOY Revenue Growth in Q3 2024 Financials
UK-based pharmaceutical giant AstraZeneca Inc. (AZ, NASDAQ: AZN) has reported its financial performance for the...
BeiGene’s Q3 2024 Results Show 28% YOY Revenue Growth Driven by Brukinsa and Tevimbra
BeiGene Ltd (NASDAQ: BGNE; HKG: 6160; SHA: 688235), a China-based biotech company, has released its...
Bayer AG Posts Modest Q3 Growth with Strong Performance from New Pharmaceuticals
Germany-based Bayer AG (ETR: BAYN) has released its Q3 2024 financial results, reporting a 0.6%...
Zai Lab Ltd Reports 46% YOY Revenue Growth in Q3 2024 Driven by Vygart, Zejula, and Nuzyra
China-based biotech Zai Lab Ltd (NASDAQ: ZLAB; HKG: 9688) has released its Q3 2024 financial...
Legend Biotech’s Q3 Revenue Soars 67% YOY Driven by Carvykti Sales
China-based Legend Biotech Corporation (NASDAQ: LEGN) has announced its financial results for the third quarter...
InnoCare Pharma Reports 29.8% Revenue Increase in Q3 2024 Financials
Beijing-based biotech InnoCare Pharma (HKG: 9969; SHA: 688428) has released its financial report for the...
Viatris Reports Q3 2024 Global Sales of USD 3.8 Billion with a 5% YOY Decline
US generics giant Viatris (NASDAQ: VTRS) has published its financial report for the third quarter...